Advertisement

Topics

Advanced ChemTech Incorporated Company Profile

21:44 EST 11th December 2018 | BioPortfolio

Advanced ChemTech offers a wide selection of fine chemical products for the Peptide and Pharmaceutical industries.

We offer, as our main focus, custom peptide and unusual amino acid synthesis. From our pilot plant, we offer customers scale-up services and bulk pricing on a broad range of organic chemicals. We also offer a catalog of over 1,100 amino acids, resins, peptides and reagents.



Our 20 years of experience span many aspects of synthetic organic and peptide chemistries. All of our products are manufactured to exacting quality control specifications and are provided with a lot-specific certificate of analysis. HPLC traces are provided when appropriate. We are committed to US-based manufacturing to ensure the quality and service that our customers demand.

Location

5609 Fern Valley Road
Louisville
KY
40228
United States of America

Contact

Phone: 502-969-0000
Fax: 502-962-5377
Email: info@advancedchemtech.com


News Articles [337 Associated News Articles listed on BioPortfolio]

PolyMirae and SK Advanced Plan PP JV

PolyMirae, a 50:50 joint venture between LyondellBasell and South Korea’s Daelim, has announced plans to build a PP plant with SK Advanced, which is itself 30% owned by Saudi Arabia’s Adva...

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPO...

Advanced Markets gründet britisches Unternehmen

FCA-reguliertes Unternehmen mit neuer Londoner Niederlassung und Rechenzentrum LONDON, 1. November 2018 /PRNewswire/ -- Advanced Markets, ein institutioneller Anbieter von Devisenliquidität und Prime...

FDA approves first treatment for advanced form of the second most common skin cancer

FDA approves Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or cu...

EPA to require more advanced biofuel blending in 2019

The Environmental Protection Agency is reportedly planning to boost the federal mandate for advanced biofuels by 15% to 4.92  -More- 

Cabozantinib may be beneficial in advanced HCC

Memorial Sloan Kettering Cancer Center researchers found that individuals with advanced hepatocellular carcinoma who received -More- 

FDA Approves First Drug for Advanced cSCC

Cemiplimab (Libtayo), approved for advanced cutaneous squamous cell carcinoma, is intended for those not eligible for curative surgery or radiation.

Ross introduces advanced laboratory Paddle Blender

Offering advanced features for more convenient, automated powder blending and liquid spraying operation with recipe management

PubMed Articles [747 Associated PubMed Articles listed on BioPortfolio]

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer with ALK-rearrangement: A Brief Report.

Locally advanced non-small-cell lung cancer (NSCLC) is one of the most heterogeneous condition with multidimensional treatments involved. Neoadjuvant therapy was commonly considered as an optimal mana...

Contemporary management of advanced renal cell carcinoma.

Kidney cancer is the eighth most commonly diagnosed cancer in the United States, and nearly one-third of patients have locally advanced or metastatic disease at presentation. Historically, survival ou...

Peer support for people with advanced cancer: a systematically constructed scoping review of quantitative and qualitative evidence.

The number of people living with advanced cancer is increasing, and appropriate support to this population is essential. Peer support is increasingly advocated as a component of care, but little is kn...

Outcomes of Women Delivering at Very Advanced Maternal Age.

The purpose of this study was to evaluate the maternal outcome in women with very advanced maternal age (VAMA) at childbirth (>45 years) compared to advanced maternal age (35-39 and 40-44 years).

Advanced practices for care management: reflections on the Brazilian Nursing.

to explain about the Advanced Nursing Practice and to discuss the possibilities of the Advanced Practice for the management of nursing care in Brazil.

Clinical Trials [4820 Associated Clinical Trials listed on BioPortfolio]

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and maximum tolerated dose of TAK-733 in patients with advanced, nonhematologic tumors. The expansi...

A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced

This is a randomized, open-label, multicenter, comparator-controlled clinical study to compare MAR-CUTIS with Dermabond Advanced in closure of surgical incisions and lacerations ≤15 cm. ...

Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous

The purpose of Phase I of this study is to test the safety and tolerability of the investigational drug, OTS167, and that of Phase II of this study is to confirm the potential response ben...

Phase 1 Study of MKC-1 in Patients With Advanced Cancer

This is an open-label study to determine the highest dose of MKC-1 that may be administered daily on a continuous basis for patients with advanced or refractory solid tumors.

Advanced Care Management in Patients With Advanced Heart Failure

The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted b...

Companies [804 Associated Companies listed on BioPortfolio]

Advanced ChemTech Incorporated

Advanced ChemTech offers a wide selection of fine chemical products for the Peptide and Pharmaceutical industries.We offer, as our main focus, custom peptide and unusual amino acid synthesis. From our...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

SQI Diagnostics Inc.

SQI Diagnostics is a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company’s proprieta...

St Andrews Chemtech International Ltd

St Andrews ChemTech International Limited (STACI) is a privately owned company based in Cupar, Scotland (sole site) providing independent R&D and custom synthesis to the pharmaceutical industry, in th...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Advanced ChemTech Incorporated" on BioPortfolio

We have published hundreds of Advanced ChemTech Incorporated news stories on BioPortfolio along with dozens of Advanced ChemTech Incorporated Clinical Trials and PubMed Articles about Advanced ChemTech Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced ChemTech Incorporated Companies in our database. You can also find out about relevant Advanced ChemTech Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record